A boy presenting for oesophagoscopy developed myoglobinuria during convalescence from the procedure. A susceptibility to malignant hyperpyerexia was considered in the differential diagnosis but was felt to be unlikely on the basis of in vitro testing of muscle biopsy specimens. A review of relevant papers suggests that rhabdomyolysis of significant degree following suxamethonium administration may be more common than generally appreciated, particularly in children.
A ten year old boy was admitted to hospital for oesophagoscopy with a vague history of difficulty with swallowing since early childhood. On admission he was noted as being normal in terms of his developmental milestones. His weight was 46 kg and physical examination was unremarkable. In particular, there was no history suggestive of muscle disease apart from his presenting complaint.
Premedication for anaesthesia was wit'h papaveretrum 10 mg and scopolamine 0.2 mg by intramuscular injection one hour prior to surgery. Thiopentone 300 mg and suxamethonium 50 mg were given intravenously to facilitate endotracheal intubation and oesophagoscopy. Excessive muscle fasciculation was not noted and muscle relaxation appeared normal. Nitrous oxide and oxygen were given during the procedure as were a further thiopentone 75 mg and suxamethonium 25 mg. No halothane was given. The examination lasted 20 minutes and no oesophageal abnormality was noted by the surgeon.
Some three hours post-operatively after a normal recovery from anaesthesia, the patient passed dark urine. He also had a mild pyrexia (37.9°C) which persisted for a few days after surgery. Serum electrolytes taken at this time were normal and in particular he was not hyperkalaemic. Unfortunately a serum calcium estimation and renal function tests were not performed. The urinary pigment was identified as myoglobin and cleared from his urine over a period of some days. Serum creatine phosphokinase levels were grossly elevated on the evening of the procedure (> 18000 u) and gradually diminished to 1700 u on the 5th postoperative day. On that day he was discharged from hospital but was readmitted I'hree days later with a compound fracture of the humerus, sustained when he was knocked from his bicycle by a car. Surgical treatment was performed during analgesia provided by a brachial plexus block with 20 ml of 1.5 % lignocaine and 1 :200,000 adrenaline. No myoglobinuria was seen on this occasion and after a week he was disoharged for follow up as an outpatient.
Six weeks after his original admission, his history was reviewed. The patient was the youngest of ~hree boys. There was no history of untoward incidents associated with anaesthesia in either immediate or more distant family. Creatine phosphokinase levels were checked on two separate occasions early in the day with care to avoid prior muscular exertion and were found to be at the upper limit of the normal range for our laboratory. The patient was then referred for neurological assessment. Electromyographic assessment of his adductor pollicis brevis, biceps and tibialis anterior muscles revealed no abnormality. Additionally the neurologist found no clinical evidence of muscular disease. At this stage we were keen to exclude malignant hyperpyrexia (MH) as a possible basis for this boy's response, even though the clinical course had been quite atypical. In February, 1977, it became possible to have in vitro testing for MH susceptibility performed in this country. Two strips of muscle (from quadriceps) were equilibrated in Krebs saline at 37°C for 30 minutes and then 1. M. GIBBS exposed to 2% halothane, 4% halothane and suxamethonium (80 p.g/ml). None of these agents either singly or in combination lead to contracture of the muscle strips. Both the excitability and contractility of the strips were continually evaluated during the test. Tests of muscle from known patients with MH were positive. The boy has been given a "Medicalert" bracelet advising of his untoward reaction to suxamethonium.
Discussion
Robtham and Haddow (1976) have written a comprehensive review of rhabdomyolysis in children. There are multiple causes for the condition, the majority being associated with trauma or with a toxin, with genetically determined defects or with auto-immune muscle disease. There are a number of reports of the condition being associated with suxamethonium administration. In a few of these myoglobinuria was a prominent feature (Jensen et al. 1968, Airaksinen and Tammisto 1966) while in others the process was sufficiently severe to result in renal failure (Bennike and Jarnum 1964 ) . Rhabdomyolysis has also been associated with malignant hyperpyrexia (Ryan, Kagen and Hyman 1971) . This last group of workers found detectable myoglobin in plasma in 16 of 40 children given a single dose of succinyl choline but in only 1 of 30 adults treated similarly. Myoglobinuria was seen in only one of the children. It was suggested that a high dose of suxamethonium might predispose to the condition. J ensen et al. (1968) also suggested that children are more prone to rhabdomyolsis with suxamethonium than are adults.
A recent report by Schaer et al. (1977) told of rhabdomyolysis associated with suxamethonium and halothane in a nine-year-old child in whom cardiac arrest occurred. Myoglobinuria occurred during recovery from this episode.
Cardiac arrest in patients with hypercatabolic states following suxamethonium administration is well documented (Weintraub, Hersterkamp and Cooperman 1969, Roth and Wuthrich 1969) . Precipitate rises of serum potassium are known to be responsible for the cardiac dysrhythmias associated with circulatory arrest. It would be interesting to know if significant rhabdomyolysis occurred at the same time in these patients. Release of myoglobin following suxamethonium administration probably occurs in a larger number of patients than is generally appreciated.
As stated in the reports cited above it can occasionally be associated with severe renal and cardiovascular side effects. There is evidence that the degree of muscle damage is dose related (Tammisto and Airaksinen 1966) so that even in normal subjects, the dose of suxamethonium should be limited so far as is possible. This is particularly true of children in whom the likelihood of overt rhabdomyolsis is considerable (Ryan et al. 1971) . Pretreatment with d-tubocurarine (Tammisto, Leikonnen and Airaksonen 1967) limits but does not prevent rhabdomyolysis.
